» Articles » PMID: 29524431

A Critical Evaluation of the Beckman Coulter Access HsTnI: Analytical Performance, Reference Interval and Concordance

Overview
Journal Clin Biochem
Specialty Biochemistry
Date 2018 Mar 11
PMID 29524431
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: We investigated the analytical performance, outlier rate, carryover and reference interval of the Beckman Coulter Access hsTnI in detail and compared it with historical and other commercial assays.

Materials And Methods: We compared the imprecision, detection capability, analytical sensitivity, outlier rate and carryover against two previous Access AccuTnI assay versions. We established the reference interval with stored samples from a previous study and compared the concordances and variances with the Access AccuTnI+3 as well as with two commercial assays.

Results: The Access hsTnI had excellent analytical sensitivity with the calibration slope 5.6 times steeper than the Access AccuTnI+3. The detection capability was markedly improved with the SD of the blank 0.18-0.20 ng/L, LoB 0.29-0.33 ng/L and LoD 0.58-0.69 ng/L. All the reference interval samples had a result above the LoB value. At a mean concentration of 2.83 ng/L the SD was 0.28 ng/L (CV 9.8%). Carryover (0.005%) and outlier (0.046%) rates were similar to the Access AccuTnI+3. The combined male and female 99th percentile reference interval was 18.2 ng/L (90% CI 13.2-21.1 ng/L). Concordance amongst the assays was poor with only 16.7%, 19.6% and 15.2% of samples identified by all 4 assays as above the 99th, 97.5th and 95th percentiles. Analytical imprecision was a minor contributor to the observed variances between assays.

Conclusion: The Beckman Coulter Access hsTnI assay has excellent analytical sensitivity and precision characteristics close to zero. This allows cTnI measurement in all healthy individuals and the capability to identify numerically small differences between serial samples as statistically significant. Concordance in healthy individuals remains poor amongst assays.

Citing Articles

Diagnostic Performance of Point-of-Care High-Sensitivity Troponin in the Exclusion of Non-ST-Elevation Myocardial Infarction in the Emergency Department.

Zalama-Sanchez D, Del Pozo Vegas C, Sanz-Garcia A, de Santos-Castro P, Presencio-Dominguez J, Gonzalez-Izquierdo P J Pers Med. 2024; 14(7).

PMID: 39064016 PMC: 11277698. DOI: 10.3390/jpm14070762.


Investigating outlier rates of cardiac troponin I and troponin T assays: A systematic review.

Zhang L, Zhu J, Zhang S, Fu H Heliyon. 2024; 10(1):e23788.

PMID: 38205298 PMC: 10776999. DOI: 10.1016/j.heliyon.2023.e23788.


Prognostic value of high-sensitivity cardiac troponin I early after coronary artery bypass graft surgery.

Nanni S, Garofalo M, Schinzari M, Nardi E, Semprini F, Battistini P J Cardiothorac Surg. 2022; 17(1):280.

PMID: 36319986 PMC: 9628166. DOI: 10.1186/s13019-022-02027-x.


Frequency histograms of three high-sensitivity cardiac troponin assays in a reference population.

Cho H, Kim H, Lee J, Kim S, Lee H, Kwon H J Clin Lab Anal. 2022; 36(6):e24432.

PMID: 35441734 PMC: 9169213. DOI: 10.1002/jcla.24432.


Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T.

du Fay de Lavallaz J, Prepoudis A, Wendebourg M, Kesenheimer E, Kyburz D, Daikeler T Circulation. 2022; 145(24):1764-1779.

PMID: 35389756 PMC: 10069758. DOI: 10.1161/CIRCULATIONAHA.121.058489.